What Immuneel Therapeutics does
Founded in 2018, Immuneel Therapeutics operates in Health Tech industry. Transitioning from research and development to clinical trials and commercialization, it secured funding in an extended Series A round to advance its treatment pipeline. Competing with companies such as Pandorum Technologies and String Bio.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Immuneel Therapeutics yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.